What are the opening hours?

Monday 8:30am - 4:30pm Tuesday 8:30am - 6:30pm Wednesday 8:30am - 4:30pm Thursday 8:30am - 4:30pm Friday 8:30am - 4:30pm

Copley Scientific

Home
United Kingdom
Nottingham
Copley Scientific

Call Website

The company is also active in detergent testing.

Founded in 1946, Copley Scientific is recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of test systems for other pharmaceutical dosage forms.

22/10/2026

Temperature, relative humidity and electrostatics can each influence inhaler testing independently. However, considering them in isolation could mean overlooking important influences on your testing.

When unexpected variability arises in test results, the formulation, device or method may not be the only factors worth investigating. Environmental influences could also be contributing.

Read our whitepaper to understand why these factors should be considered together, and discover practical solutions to help manage environmental variability in the lab.

Download here ➡️ https://bit.ly/4icV6gf

21/10/2026

Day one of the MVIC Symposium 2026 is underway in Lund, Sweden! 🫁

As the symposium brings together experts to explore advances in inhaled medicine development, we're highlighting the role of connected inhaler testing in supporting this progress.

Our new Critical Flow Controller TPK 200iX and Inhalytix®+ v2.0 software bring equipment, methods and data into a more connected digital workflow, helping laboratories achieve greater control, consistency and traceability throughout the inhaler testing process.

Attending MVIC? Stop by our exhibition stand to meet Paul Martin, Head of Business Development, see the new TPK 200iX and Inhalytix®+ v2.0 up close and learn how connected inhaler testing could benefit your laboratory.

We look forward to seeing you there!

15/10/2026

Attending Topical and Inhaled Drugs: New Guidelines and Scientific Perspectives this week? Our distributor, BLG Kimya, will be representing Copley Scientific in Turkey from 15-18 October 2026.

Bringing together researchers, scientists and industry professionals, the event will explore the latest scientific developments, evolving regulatory guidelines and key considerations in topical and inhaled drug delivery.

If you're attending, be sure to connect with the BLG Kimya team to discuss your inhaled drug testing requirements and learn more about how Copley's solutions can support your testing needs.

📢 Interested in how revised FDA guidelines are shaping bioequivalence testing for inhaled products?

Join our upcoming webinar, From Guidance to Practice: Navigating Revised FDA PSGs for Inhaled Products, on 28 October 2026, where we'll explore recent revisions to FDA Product-Specific Guidances (PSGs) and their implications for in vitro testing and bioequivalence assessment.

🔗 Register your place at the webinar: https://bit.ly/4ynGoJt

14/10/2026

One less step. One less risk.

Small improvements to everyday testing workflows can make a meaningful difference in the laboratory.

With the new Critical Flow Controller TPK 200iX, the 7-series vacuum pumps can be activated automatically when a test is initiated, removing reliance on manual pump operation.

Traditionally, vacuum pumps have required manual activation before inhaler testing begins. This can lead to unnecessary pump runtime, or if activation is forgotten, tests being initiated without vacuum, potentially resulting in voided assessments, wasted product and additional cleaning.

⚙️Discover how automatic pump control can benefit your laboratory:
https://bit.ly/4yRDYDS

12/10/2026

This week, we're heading across the pond to the US, where our CEO, Jamie Clayton, will be representing Copley Scientific as a panellist at Advancing Bioequivalence Frameworks for Inhalation Drug Products from 14–15 October.

Co-hosted by the FDA and the Center for Research on Complex Generics (CRCG), the workshop brings together experts from industry, academia and regulatory bodies to explore advances in in vitro, in vivo and in silico approaches to bioequivalence assessment.

Jamie will share his expertise in OINDP testing, contributing to discussions on the evolving analytical and regulatory considerations shaping inhaler testing strategies and workflows.

As approaches to demonstrating bioequivalence continue to evolve, understanding what these developments mean for testing practice is increasingly important.

That’s also the focus of our upcoming webinar on 28 October, From Guidance to Practice: Navigating Revised FDA PSGs for Inhaled Products, focusing on recent guidance revisions and their practical implications for inhaler testing.

🔗 Register for the webinar: https://bit.ly/4rQbiZa

08/10/2026

There’s still time to register for our upcoming webinar on the FDA’s revised Product-Specific Guidances (PSGs) for generic inhaled products.

Join us on Wednesday 28 October as we take a practical look at what the latest revisions could mean for OINDP development and bioequivalence assessment.

We’ll explore:
• How to approach the proposed in vitro studies
• Key considerations for study design and method suitability
• What regulators may look for when assessing the resulting data

📅 Wednesday 28 October
⏰ 9:00am or 5:00pm GMT

Secure your place to find out how the changes affect you: https://bit.ly/4rQbiZa

06/10/2026

🫁Inhaled drug development is evolving and so are the questions testing strategies need to answer.

The recent Intertek Inhaled & Nasal Biologics DNA Forum 2026 brought together discussions spanning emerging biologics, novel formulations and new approaches to respiratory delivery.

For us, one of the most interesting themes was what increasing product complexity could mean for aerosol testing; from formulation and device considerations to the role of different performance assessments throughout development.

In our latest carousel, we share the key points that stood out and consider what they could mean for your inhaler testing workflows.

➡️Swipe through for our key takeaways.

01/10/2026

📢 USP Disintegration Update

From 1 October 2026, the revised USP Disintegration chapter comes into effect, introducing a new Test B basket-rack assembly for dosage forms greater than 18 mm on their longest axis.

✅ Our DTGi Disintegration Tester Series already supports the updated requirements.

At Copley, we continuously monitor pharmacopoeial developments, helping ensure our testing solutions keep pace with our evolving requirements.

⚙️ Make sure your disintegration testing is ready
Discover how the DTGi Series supports compliant disintegration testing: https://bit.ly/4iZGzXh

🔎 Review the USP update
See the revised requirements directly from USP: https://www.usp.org/harmonization-standards/pdg/general-methods/disintegration

30/09/2026

Last weekend, members of the Copley Scientific team took on the Robin Hood Mini Marathon and Half Marathon in support of Asthma + Lung UK.

It was a brilliant day of teamwork, determination and plenty of encouragement, with colleagues coming together to take on the challenge for a cause that has a particularly strong connection to the work we do.

A huge well done to everyone who took part, supported the team and helped make the day such a success; a great example of what can be achieved through hard work and team spirit.

Well done, Team Copley! 👏🏃‍♀️🏃‍♂️

25/09/2026

It’s been a busy start to the autumn conference season for our team in China, with three events across three cities in just three weeks: the CMC Inhalation Preparation Conference in Suzhou, Aptar’s IDDS conference in Beijing, and the 3rd Symposium on Key Technologies of Inhalation Preparations in Nanjing.

Across all three events, Dr Anny Shen presented on a key theme shaping inhaled drug development today: generating more patient-relevant in vitro data.

Dr Shen’s presentations explored IVIVC testing using Idealised Throats and realistic breathing profiles with the Breathing Simulator BRS 300i, alongside dissolution testing with the Inhaled Dissolution Apparatus™ IDA and its growing relevance within Product-Specific Guidances.

It was a valuable opportunity to connect with colleagues across the inhalation community, exchange perspectives on current testing challenges, and continue the conversation around more clinically relevant approaches to OINDP development.

Want to explore how more representative in vitro testing can help improve IVIVCs?

Read our 3-part blog series here: https://bit.ly/4z1LT1g

Address

Colwick Quays Business Park
Nottingham
NG42JY

Opening Hours

Monday	8:30am - 4:30pm
Tuesday	8:30am - 6:30pm
Wednesday	8:30am - 4:30pm
Thursday	8:30am - 4:30pm
Friday	8:30am - 4:30pm

Telephone

+441159616229

Website

http://www.copleyscientific.com/

Alerts

Be the first to know and let us send you an email when Copley Scientific posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

D&L reinstatements- Resin driveways, Tarmac W

Want your business to be the top-listed contractor in Nottingham?